Wikidata

(Q62823022)

English

Pembrolizumab, Ixazomib Citrate, and Dexamethasone in Treating Participants With Relapsed Multiple Myeloma

clinical trial

In more languages

Statements

title
Phase 2 Trial of Pembrolizumab, Ixazomib, and Dexamethasone for Relapsed Multiple Myeloma (English)
0 references
sponsor
Mayo Clinic
0 references
start time
19 June 2018
0 references
end time
29 March 2024
0 references
number of participants
41
0 references
research intervention
(RS)-cyclophosphamide
0 references
dexamethasone acetate
0 references
pembrolizumab
0 references
ixazomib
0 references
citric acid
0 references
trisodium citrate
0 references
glycine
0 references
research site
Mayo Clinic
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62823022&oldid=2035754223"